Trial Profile
Micro and Macro Arteriolar Blockade of Hepatocellular Carcinoma (HCC): Treatment With Sorafenib Before and After Hepatic Arterial Embolization (HAE) Therapy for Liver Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Doxorubicin; Mitomycin
- Indications Liver cancer
- Focus Adverse reactions
- 13 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 11 Aug 2009 New trial record